Osteoarthritis, Hip Clinical Trial
Official title:
A Randomized Clinical Trial Comparing Two Manipulative Protocols to Assess Changes in Pain, ROM, Quality of Life, Cost and Risk for Falls in Subjects With Hip Osteoarthritis
Purpose of this study is to examine the effect of chiropractic adjusting (manipulative therapy) and rehabilitation on hip osteoarthritis (hip OA) in older adults.
Patients seek treatment from chiropractors for (OA). OA is the fifth most reported and
treated disorder in medical practice. Osteoarthritis of the hip (OAH), a subset, affects ≥12
million American adults and leads to pain, loss of mobility, decreased: function, strength,
activities of daily living, quality of life and is a significant risk factor for falls.
Medical care prescribed for OAH is lifestyle accommodation (a cane, high chairs and toilet
seats, etc), non-steroidal anti-inflammatory drugs (NSAIDS), anti-arthritics, steroids,
various and sundry prescription and non-prescription medications and exercise. Randomized
controlled trials (RCTS) support exercise for knee OA (KOA) treatment, proven superior to
placebo, less so for OAH. Ninety-two percent of patients with OAH use NSAIDS. Frequent minor
and intermittently serious adverse reactions to chronic use of NSAIDS and evidence that
manipulative/manual therapy (MAN) and exercise/rehabilitation therapy may give equivalent
relief, suggests NSAIDS should be infrequently used. Supported by an earlier RCT that
demonstrated manual, soft tissue and exercise therapy for KOA superior to placebo; later
this protocol was found superior to exercise. A similar multimodal (multimodal = MAN with 2
or more combined treatments) 2004 RCT compared exercise protocol versus MAN combined with
passive and active stretch for OAH. Early, superior relief and function was achieved with
multimodal MAN. This suggests multimodal MAN (manipulative) therapy may be a superior
treatment.
In studies that followed multimodal MAN over a year (without minimal, later, PRN or
supportive treatment given) all treatment benefits begin to decrease toward a similar mean).
One feature frequently inherent in previous trial design has no availability of additional
brief treatment rounds subsequent to a short course of interventional therapy. Researchers
typically design interventions in search of evaluating short-term interventional strategies
where sustained improvements in symptom relief, function, and QoL (quality of life) will be
achieved. The current investigators question the utility of such an approach. Frequently
patients experience minor setbacks in their improvement secondary to minor injuries or
diminution in compliance over time with exercise programs. Combining the practical awareness
of patient experience during the follow-up interval with the reality of the typically
ongoing nature of OA activity has stimulated the need for some reasonable level of and
access to follow-up care after the initial treatment course. A patient who has responded to
the initial brief intervention course but who subsequently requires an occasional office
visit for physical re-evaluation, review of exercise and a visit or two of manual methods is
not inherently synonymous with a failed interventional approach any more that repeat doses
of pharmaceuticals are required for other chronic conditions whether it be NSAIDs for OA or
insulin for diabetes.
Significant morbidity and occasional mortality from NSAID and drug-related complications and
surgery; difficulty in obtaining compliance with prolonged exercise protocols; apparent
equivalent (manipulative) outcomes (in pain relief, mobility and function); falls with
appalling sequela in morbidity, mortality and expense, justifies further research into
multimodal manipulative therapy for treatment of OAH. Data suggests such therapy may give
earlier, effective, less costly outcomes and reflects a common clinical chiropractic
approach to OAH. In addition to the hip joint, OAH disability is significantly worsened by
restricted knee flexion; and in a similar vein, KOA is made worse by hip joint stiffness and
dysfunction. Manipulative therapy to a fuller, or the full, kinetic chain (lumbosacral
through foot) appears superior for Knee and hip OA. The 2nd, new protocol (protocol 2) will
be compared to the 1st (or Hoeksma et al like protocol 1). Additional PRN treatment for both
protocols is added to maintain or restore peak levels of improvement (see above and below).
Specific Aim 1: Recruit a pool of HOA patients from senior centers, the local community,
medical and chiropractic clinics, and through advertising in collaboration with other
Universities/Colleges or Schools.
Specific Aim 2: Establish protocols for long-term surveillance of OAH in chiropractic
patients. This study will take 2 years. Recruitment will be during the first 9 months. Core
measurements and data will be collected: at baseline; blind measurements after the 9th
treatment, and 3, 6, and a 9 month follow up. After the end of the 9th treatment(per
protocol 2), additional PRN treatment 1-3 visits every 1-3 months up to 6 months (not to
exceed 6 additional visits before 9 months after beginning care).
Specific Aim 3: integrate a clinical research program with a teaching clinic system.
Specific Aim 4: Analysis: collect and compare outcome data comparing protocols. Primary
outcome measure: The McMaster Overall Therapy Effectiveness (the OTE) Tool for determining
general improvement, satisfaction and the importance of changes to, and experienced by, the
patient. Secondary outcome measures: WOMAC, Harris Hip Scale, Goniometry, the One Legged
Standing test and Berg Balance Scale.
Specific Aim 5: Cost Includes tracking: time, procedures and costs at each visit by CPT
codes. CPT data will be analyzed by various means after completion of the trial.
a) Minimum outcome measure: Appropriate CPT codes marked at all visits.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05773261 -
Clinical Investigation Comparing Two Different Ultra-porous Coated Surfaces of Uncemented Cups
|
N/A | |
| Recruiting |
NCT05223777 -
KINCISE™ Surgical Automated System in Total Hip Arthroplasty (THA)
|
N/A | |
| Recruiting |
NCT04731077 -
Avenir Complete Post-Market Clinical Follow-Up Study
|
N/A | |
| Not yet recruiting |
NCT04448106 -
Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis
|
Phase 2 | |
| Completed |
NCT05070871 -
A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women
|
N/A | |
| Not yet recruiting |
NCT06162195 -
The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
|
N/A | |
| Withdrawn |
NCT02743208 -
Evaluation of a Short Femoral Stem in Total Hip Arthroplasty
|
N/A | |
| Completed |
NCT02944448 -
A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee
|
Phase 2 | |
| Active, not recruiting |
NCT02229279 -
Evaluation of Teleconsulting on Rehabilitation After Hip and Knee Surgical Procedures
|
N/A | |
| Active, not recruiting |
NCT02851992 -
A Prospective Study to Evaluate Long-term Clinical Outcomes of the GTS Cementless Femoral Stem
|
N/A | |
| Completed |
NCT01618708 -
A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip
|
N/A | |
| Completed |
NCT01700933 -
Dose-response: Exercise Therapy on Hip Osteoarthritis
|
N/A | |
| Completed |
NCT01214954 -
Early Rehabilitation After Total Hip Replacement
|
N/A | |
| Active, not recruiting |
NCT00294424 -
Study on Costs and Effects of Waiting Time in Total Hip and Knee Replacements
|
N/A | |
| Terminated |
NCT00588861 -
Total Hip Replacement With the Answer® Hip Stem and Ranawat/Burnstein® Shell Using Simplex® or Palacos® Bone Cement
|
N/A | |
| Withdrawn |
NCT05054595 -
Audio-Recorded vs. Nurse-Led Brief Mindfulness-Based Intervention
|
N/A | |
| Terminated |
NCT00973141 -
A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain
|
Phase 2 | |
| Recruiting |
NCT05014113 -
H-28 DELTA ST-C and Minima Retrospective Study.
|
||
| Completed |
NCT01066936 -
Mini Stem DEXA (Dual Energy X-ray Absorptiometry)
|
||
| Recruiting |
NCT06185036 -
Histological Validation of dGEMRIC Indices as a Quantitative Biomarker for Cartilage Damage in the Hip Joint
|